Improved Survival in Lymphoma Patients Receiving Sirolimus for Graft-Versus-Host Disease Prophylaxis After Allogeneic Hematopoietic Stem-Cell Transplantation With Reduced-Intensity Conditioning

Armand Philippe; Gannamaneni Supriya; Kim Haesook T.; Cutler Corey S.; Ho Vincent T.; Koreth John; Alyea Edwin P.; LaCasce Ann S.; Jacobsen Eric D.; Fisher David C.; Brown Jennifer R.; Canellos George P.; Freedman Arnold S.; Soiffer Robert J.; Antin Joseph H.

首页> 外文期刊>Journal of Clinical Oncology >Improved Survival in Lymphoma Patients Receiving Sirolimus for Graft-Versus-Host Disease Prophylaxis After Allogeneic Hematopoietic Stem-Cell Transplantation With Reduced-Intensity Conditioning

【24h】

Improved Survival in Lymphoma Patients Receiving Sirolimus for Graft-Versus-Host Disease Prophylaxis After Allogeneic Hematopoietic Stem-Cell Transplantation With Reduced-Intensity Conditioning

机译：降低强度条件的异基因造血干细胞移植后接受西罗莫司用于抗移植物抗宿主病的淋巴瘤患者的存活率提高

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Purpose

机译：目的

著录项

来源
《Journal of Clinical Oncology》 |2008年第35期|共8页
作者
Armand Philippe; Gannamaneni Supriya; Kim Haesook T.; Cutler Corey S.; Ho Vincent T.; Koreth John; Alyea Edwin P.; LaCasce Ann S.; Jacobsen Eric D.; Fisher David C.; Brown Jennifer R.; Canellos George P.; Freedman Arnold S.; Soiffer Robert J.; Antin Joseph H.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Improved Survival in Lymphoma Patients Receiving Sirolimus for Graft-Versus-Host Disease Prophylaxis After Allogeneic Hematopoietic Stem-Cell Transplantation With Reduced-Intensity Conditioning [J] . Armand Philippe, Gannamaneni Supriya, Kim Haesook T., Journal of Clinical Oncology . 2008,第35期

机译：降低强度条件的异基因造血干细胞移植后接受西罗莫司用于抗移植物抗宿主病的淋巴瘤患者的存活率提高
2. Improved outcomes using tacrolimus/sirolimus for graft-versus-host disease prophylaxis with a reduced-intensity conditioning regimen for allogeneic hematopoietic cell transplant as treatment of myelofibrosis. [J] . Snyder DS, Palmer J, Gaal K, Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2010,第2期

机译：使用他克莫司/西罗莫司预防移植物抗宿主病，以及降低强度的同种异体造血细胞移植治疗骨髓纤维化的条件改善方案。
3. Comparison of Tacrolimus and Sirolimus (Tac/Sir) versus Tacrolimus, Sirolimus, and mini-methotrexate (Tac/Sir/MTX) as acute graft-versus-host disease prophylaxis after reduced-intensity conditioning allogeneic peripheral blood stem cell transplantation. [J] . Ho VT, Aldridge J, Kim HT Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2009,第7期

机译：在降低强度的同种异体外周血干细胞移植后，他克莫司和西罗莫司（Tac / Sir）与他克莫司，西罗莫司和小型甲氨蝶呤（Tac / Sir / MTX）作为急性移植物抗宿主病预防的比较。
4. Interactive environment for hematopoietic stem-cell transplant patients [C] . Mieko Ohsuga, Yuma Tada, Jun Ishikawa International Conference on Virtual Rehabilitation . 2017

机译：造血干细胞移植患者的互动环境
5. Symptoms, Cytokines, and Quality of Life of Patients with Chronic Graft-versus-Host Disease following Allogeneic Hematopoietic Stem Cell Transplantation. [D] . Kelly, Debra Lynch. 2014

机译：异基因造血干细胞移植后慢性移植物抗宿主病患者的症状，细胞因子和生活质量。
6. Improved Survival in Lymphoma Patients Receiving Sirolimus for Graft-Versus-Host Disease Prophylaxis After Allogeneic Hematopoietic Stem-Cell Transplantation With Reduced-Intensity Conditioning [O] . Philippe Armand, Supriya Gannamaneni, Haesook T. Kim, -1

机译：降低强度条件的同种异体造血干细胞移植后接受西罗莫司预防移植物抗宿主病的淋巴瘤患者的生存率提高
7. Improved Survival in Lymphoma Patients Receiving Sirolimus for Graft-Versus-Host Disease Prophylaxis After Allogeneic Hematopoietic Stem-Cell Transplantation With Reduced-Intensity Conditioning [O] . Armand, Philippe, Gannamaneni, Supriya, Kim, Haesook T., 2008

机译：降低强度条件的异基因造血干细胞移植后接受西罗莫司预防移植物抗宿主病的淋巴瘤患者的生存率提高

Improved Survival in Lymphoma Patients Receiving Sirolimus for Graft-Versus-Host Disease Prophylaxis After Allogeneic Hematopoietic Stem-Cell Transplantation With Reduced-Intensity Conditioning

摘要

著录项

相似文献

相关主题

期刊订阅